Harvard Catalyst Child Health Symposium to Explore Genome Biology
On October 8, the Harvard Catalyst Child Health Program will host its inaugural symposium Transforming Child Health Through Genome Biology. This afternoon program (2:00-5:30pm), to be held at the Joseph B. Martin Center, will explore the strengths and successes of new genetics in childhood disorders, address the ethical and operational challenges around testing patients, and discuss the future of this area of study. Alan E. Guttmacher, MD, director of the National Institute of Child Health and Human Development at the National Institutes of Health, Diana W. Bianchi, MD, executive director of the Mother Infant Research Institute at Tufts Medical Center, and Joshua Boger, PhD, founder and former CEO of Vertex Pharmaceuticals are the featured speakers for the symposium.
In addition to exploring the topic of child health and genome biology, the symposium will convene researchers across Harvard and affiliated hospitals to promote collaborative work and innovation on topics relevant to children and child health.
Registration is required.
Harvard Catalyst’s Child Health Program works to foster the development of programs, resources, and strategies that support innovative and collaborative research to improve the health and well-being of children. The program works across Harvard University, its affiliated institutions, and the national CTSA Consortium.